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Abstract
Objective:  Describe  the  clinical  and  laboratory  proﬁle,  follow-up,  and  outcome  of  a  series  of
cases of  acute  viral  myositis.
Method:  A  retrospective  analysis  of  suspected  cases  under  observation  in  the  emergency
department  was  performed,  including  outpatient  follow-up  with  the  recording  of  respiratory
infection and  musculoskeletal  symptoms,  measurement  of  muscle  enzymes,  creatine  phosphoki-
nase (CPK),  lactate  dehydrogenase  (LDH),  transaminases  (AST  and  ALT),  blood  count,  C-reactive
protein, and  erythrocyte  sedimentation  rate  in  the  acute  phase  and  during  follow-up  until
normalization.
Results: Between  2000  and  2009,  42  suspected  cases  were  identiﬁed  and  35  (27  boys)  were
included.  The  median  age  was  7  years  and  the  diagnosis  was  reported  in  89%  in  the  ﬁrst  emer-
gency visit.  The  observed  respiratory  symptoms  were  cough  (31%),  rhinorrhea  (23%),  and  fever
(63%), with  a  mean  duration  of  4.3  days.  Musculoskeletal  symptoms  were  localized  pain  in  the
calves (80%),  limited  ambulation  (57%),  gait  abnormality  (40%),  and  muscle  weakness  in  the
lower limbs  (71%),  with  a  mean  duration  of  3.6  days.  There  was  signiﬁcant  increase  in  CPK
enzymes  (5507  ±  9180  U/L),  LDH  (827  ±  598  U/L),  and  AST  (199  ±  245  U/L),  with  a  tendency  to
leukopenia (4590  ±  1420)  leukocytes/mm3.  The  complete  recovery  of  laboratory  parameters
was observed  in  30  days  (median),  and  laboratory  and  clinical  recurrence  was  documented  in
one case  after  10  months.
Conclusion:  Typical  symptoms  with  increased  muscle  enzymes  after  diagnosis  of  inﬂuenza  and
self-limited  course  of  the  disease  were  the  clues  to  the  diagnosis.  The  increase  in  muscle Please cite this article as: Cardin SP, Martin JG, Saad-Magalhães C. Clinical and laboratory description of a series of cases of acute viral
yositis. J Pediatr (Rio J). 2015;91:442--47.
 Study conducted at the Department of Pediatrics, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista (UNESP), Botucatu,
P, Brazil.
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enzymes  indicate  transient  myotropic  activity  related  to  seasonal  inﬂuenza,  which  should  be
considered,  regardless  of  the  viral  identiﬁcation,  possibly  associated  with  inﬂuenza  virus  or
other respiratory  viruses.
© 2015  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.
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Descric¸ão  clínico-laboratorial  de  uma  série  de  casos  de  Miosite  Aguda  Viral
Resumo
Objetivo:  Descrever  o  perﬁl  clínico-laboratorial,  acompanhamento  e  desfecho  de  uma  série  de
casos de  Miosite  Aguda  Viral.
Método:  Foi  conduzida  uma  análise  retrospectiva  de  casos  suspeitos,  em  observac¸ão  em
unidade de  emergência,  e  seguimento  ambulatorial  com  o  registro  de  sintomas  de  infecc¸ão
respiratória,  sintomas  músculo-esqueléticos,  determinac¸ão  de  enzimas  musculares,  creatina-
fosfoquinase  (CPK),  desidrogenase  lática  (DHL),  transaminases  (AST  e  ALT),  hemograma,
proteína C  reativa  e  velocidade  de  hemossedimentac¸ão,  na  fase  aguda  e  acompanhamento,
até a  normalizac¸ão.
Resultados:  Entre  2000  e  2009,  42  casos  suspeitos  foram  identiﬁcados  e  35  (27  meninos)  foram
incluídos.  A  mediana  de  idade  foi  7  anos  e  o  diagnóstico  relatado  em  89%,  na  primeira  visita
de emergência.  Os  sintomas  respiratórios  observados  foram:  tosse  (31%),  coriza  (23%),  e  febre
(63%) com  durac¸ão  media  de  4,3  dias.  Os  sintomas  músculo-esqueléticos  foram:  dor  localizada
nas panturrilhas  (80%),  deambulac¸ão  limitada  (57%),  marcha  anormal  (40%),  fraqueza  muscular
nos membros  inferiores  (71%),  com  durac¸ão  média  de  3,6  dias.  Observou-se  elevac¸ão  importante
das enzimas  CPK  (5507  ±  9180)  U/l,  DHL  (827  ±  598)  U/l  e  AST  (199  ±  245)  U/l,  e  tendência  a
leucopenia  (4590  ±  1420)  leucócitos/mm3.  A  recuperac¸ão  complete  dos  parâmetros  laboratori-
ais foi  observada  em  30  dias  (mediana)  e  a  recaída  clínica  e  laboratorial  em  um  caso  após  10
meses.
Conclusão: Os  sintomas  típicos  com  enzimas  musculares  elevadas  após  diagnóstico  de  Inﬂuenza
e o  curso  auto-limitado  foram  os  indícios  para  o  diagnóstico.  A  elevac¸ão  de  enzimas  musculares
indicam a  atividade  miotrópica  transitória  relacionada  à  inﬂuenza  sazonal  que  deve  ser  con-
siderada, à  despeito  da  identiﬁcac¸ão  viral,  possivelmente  associada  com  o  vírus  Inﬂuenza  ou
outros vírus  respiratórios.
© 2015  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os  direitos
reservados.
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Acute  viral  myositis  is  a  syndrome  characterized  by  muscu-
loskeletal  impairment  after  upper  airway  disorders,  which
leads  to  temporary  limited  ambulation  in  children  and  is  pre-
dominant  in  boys.  It  manifests  as  muscle  pain  and  lower-limb
weakness,  especially  in  the  calves  and  thighs.1--4 Its  inci-
dence  is  unknown,  but  it  is  considered  rare  and  is  described
mainly  during  inﬂuenza  outbreaks.5 The  preceding  respira-
tory  symptoms  are  common,  including  fever,  malaise,  cough,
odynophagia,  headache,  and  rhinorrhea.
Musculoskeletal  signs  and  symptoms  --  although  transient
and  often  self-limited  --  require  emergency  care,  are  of
concern  to  parents,  and  cause  some  diagnostic  difﬁculties,
especially  regarding  limited  ambulation.
There  are  literature  reports  of  isolated  cases,  small
series,  or  epidemic  outbreaks.2,6--12 Research  on  its  patho-
genesis  is  still  limited.  The  early  recognition  of  the  disease
may  improve  emergency  care  and  conservative  treatment.
The  objective  was  to  explore  and  describe  the  clinical  and
laboratory  presentation  and  outcome  of  a  series  of  cases  of
acute  viral  myositis.
ﬁ
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oethods
 retrospective  study  of  patients  treated  in  an  emergency
are  unit  from  June  2000  to  2009  was  performed.  The  cases
ere  initially  identiﬁed  by  the  diagnostic  records  during
utpatient  follow-up.  A  demographic  and  clinical  data  col-
ection  protocol  was  used  for  medical  record  review:  1 --
emographic:  date  of  birth,  gender,  initial  diagnosis,  origin,
onsulted  specialties,  referral,  date  of  ﬁrst  appointment,
ate  of  last  appointment;  2  --  clinical:  date  of  symptom
nset,  date  of  diagnosis,  time  to  symptom  resolution,  clin-
cal  signs  of  presentation,  including  respiratory  signs  and
ymptoms  and  duration,  associated  diseases,  family  history,
ospitalization  and  length  of  stay,  complications;  3  --  lab-
ratory:  laboratory  tests  at  diagnosis  and  follow-up;  4  --
utcome:  treatment  and  disease  duration.  The  suspected
onsecutive  cases  were  observed  in  a  public  hospital  by
ifferent  assistant  physicians;  clinical  evaluation,  from  the
rst  to  the  last  visit,  was  recorded  in  the  chart,  identifying
uring  this  interval  the  date  of  diagnosis,  date  of  symptom
nset,  and  the  date  when  laboratory  test  normalization  was
bserved,  as  well  as  their  values.  The  duration  of  initial
4 Cardin  SP  et  al.
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ymptoms  and  complications,  as  well  as  the  identiﬁcation
f  respiratory  symptoms,  musculoskeletal  symptoms,  and
ecurrence  were  identiﬁed  in  outpatient  visits.  Possible  dif-
erential  diagnoses  considered  during  the  emergency  care
ere  recorded  in  the  protocol.
The  laboratory  tests  were  requested  by  the  attending
hysician  according  to  the  clinical  suspicion  or  diagnos-
ic  referral  in  the  emergency  room  and  consisted  of  the
ollowing:  measurement  of  muscle  enzymes,  creatine  phos-
hokinase  (CPK)  and  its  isoenzyme,  CK-MB  fraction  (CK-MB),
actate  dehydrogenase  (LDH),  aspartate  transaminase  (AST),
nd  alanine  aminotransferase  (ALT),  performed  in  the  rou-
ine  hospital  laboratory,  using  a  colorimetric  enzyme  assay
ith  results  expressed  in  units  per  liter  (U/L).  Blood  count
nd  urinalysis  were  performed  by  routine  methods,  as  well
s  erythrocyte  sedimentation  rate  (Westergreen  method),
ith  results  expressed  in  mm/h,  while  C-reactive  protein
as  measured  by  an  automated  nephelometric  assay  and
esults  were  expressed  in  mg/dL.
As  there  are  no  standardized  criteria  for  the  diagnosis  of
cute  viral  myositis,  the  protocol  was  established  accord-
ng  to  the  symptoms  most  often  described  in  the  literature,
.e.,  pain  in  the  limbs  and  muscle  weakness  accompanied
y  elevated  muscle  enzymes.  Cases  that  met  the  following
riteria  were  included:  age  <  18  years  with  clinical  suspicion
onﬁrmed  during  outpatient  follow-up,  from  2000  to  2009,
ith  clinical  and  laboratory  assessment  at  diagnosis  and  at
east  one  follow-up  visit.  Suspected  cases  that  did  not  have
levated  muscle  enzymes  were  excluded,  despite  the  symp-
oms  of  myalgia  --  limb  pain  with  self-limited  evolution  --
ccurring  after  respiratory  infection.
Variable  frequency  was  recorded,  including  gender;  pri-
ary  diagnosis,  origin;  consulted  specialties;  complications;
dditional  requested  tests  and  altered  laboratory  tests;
ssociated  diseases;  and  the  presence  of  clinical  signs,
ainly  myalgia,  pain  in  the  calves,  limited  ambulation,  and
ait  abnormality,  such  as  walking  on  tiptoe  and  muscle  weak-
ess.  The  preceding  respiratory  symptoms,  such  as  sneezing,
asal  obstruction,  cough,  rhinorrhea,  fever,  headache,  sore
hroat,  vomiting,  diarrhea,  epistaxis,  pharyngotonsillitis,
nd  use  of  medications  were  also  recorded.  The  protocol  was
pproved  by  the  ethics  committee  for  institutional  research
n  December  7,  2009  (No.  3409/2009).
Statistical  analysis  was  performed;  quantitative  data
re  shown  as  medians,  minimum  and  maximum  values,
nd  means  and  standard  deviations;  categorical  variables
re  shown  as  absolute  values  and  percentages.  The  fre-
uency  and  the  annual  distribution  of  cases  are  shown
s  frequency  histogram.  The  comparison  between  labora-
ory  variables  at  clinical  presentation  and  during  symptom
esolution  (time  variable)  was  performed  using  the  paired
-test,  with  the  signiﬁcance  threshold  set  at  5%  (p  <  0.05).
he  tests  were  performed  and  the  charts  created  using
rism  Graph  Pad  v.4.0® (GraphPad  Software  Inc.,  California,
SA).
esults total  of  42  cases  with  clinical  suspicion  of  acute  viral
yositis  were  identiﬁed  in  emergency  care  and  outpatient
linic  records,  from  June  of  2000  to  December  of  2009.  Of
t
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oigure  1  Frequency  and  monthly  distribution  of  cases  of
cute viral  myositis  in  2000--2009.
hese,  35  cases  were  included,  27  boys  and  8  girls,  with  one
ase  of  recurrence  in  a  second  episode.
The  annual  distribution  of  cases  and  the  frequency
ccording  to  the  months  of  the  year  is  shown  in  Fig.  1,  with
 higher  frequency  in  the  months  of  May,  June,  July,  and
eptember,  when  compared  to  the  others,  corresponding  to
he  colder  months  of  the  year.  There  was  a  higher  frequency
f  cases  diagnosed  from  2004  to  2006.
The  age  of  symptom  onset  ranged  from  3.4  to  12.5
ears,  with  a  median  of  7.5  years.  The  interval  between
ymptom  onset  and  the  ﬁrst  consultation  ranged  from  1
o  6  days.  The  duration  of  respiratory  symptoms  ranged
rom  1  to  15  days,  with  a  median  of  3.5  days  and  mean
f  4.3  ±  2.8  days.  Among  the  reported  symptoms,  fever,
ough,  and  rhinorrhea  were  observed  in  63%,  31%,  and  23%,
espectively.  Table  1  shows  the  musculoskeletal  signs  and
ymptoms  described  according  to  the  data  collection  proto-
ol.  Neurological  examination  was  normal  in  all  cases.  The
uration  of  muscle  weakness  ranged  from  1  to  8  days,  with
 median  of  2  days  and  mean  of  2.7  ±  1.9  days.  Symptom
esolution  ranged  from  1  to  16  days,  with  a  median  of  3
nd  mean  of  3.6  ±  3.3  days.  One-to-three  consultations  were
erformed  during  the  acute  phase  and  48-h  hospitalization
ccurred  in  4/35  (11%).  Follow-up  duration  varied  from  30
o  180  days,  with  a  median  of  32  days.
Symptomatic  treatment  of  respiratory  and  musculoskele-
al  symptoms  included  analgesics  or  anti-inﬂammatory
rugs.  Symptomatic  use  ranged  from  2  to  45  days,  with
 median  of  2  days  and  mean  of  16.3  ±  24.8  days.  Antibi-
tics  were  prescribed  in  cases  complicated  by  sinusitis  or
Acute  viral  myositis  
Table  1  Description  of  musculoskeletal  symptoms  at  pre-
sentation  in  a  series  of  cases  of  acute  viral  myositis.
Signs  and
symptoms
Number  of  cases  with
described
symptom/total
number  of  cases  with
investigated  symptom
Frequency  (%)
Diffuse  myalgia  9/35  26
Calf pain  28/35  80
Limited
ambulation
20/35  57
Gait
abnormality
14/35  40
Ankle
pain/edema
1/35 3
Localized
muscle
weakness:
25/35  71
Calves 17/25  68
Thighs 1/25  4
Overall  muscle 6/25  24
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the  involvement  is  localized  in  certain  muscle  groups  inweakness
pharyngotonsillitis.  Antibiotic  use  ranged  from  5  to  15  days,
with  a  median  of  10  days  and  mean  of  10.6  ±  3.3  days.
Laboratory  test  alterations  are  shown  in  Table  2. The
resolution  time  until  normalization  of  muscle  enzymes  and
blood  count  parameters,  as  well  as  erythrocyte  sedimenta-
tion  rate  (ESR)  and  C-reactive  protein  (CRP)  levels,  varied
from  30  to  180  (median  of  32)  days.
Only  three  (9%)  urinalysis  tests  were  indicated,  with
abnormal  results  in  one  of  the  tests,  which  showed  protein-
uria  of  2+,  but  none  indicated  myoglobinuria.  Serology  tests
were  performed,  including  toxoplasmosis  IgM+/negative
mononucleosis/Cytomegalovirus  IgG+  in  a  single  case.  In  this
case,  the  initial  diagnosis  was  unspeciﬁed  limb  pain.  No
imaging  or  electromyography  tests  were  indicated.
The  normalization  of  laboratory  parameters,  muscle
enzymes  (CPK,  CK-MB,  LDH,  AST  and  ALT)  and  the  decrease
in  AST/ALT  ratio  are  shown  in  Table  2.  A  signiﬁcant
difference  was  observed  at  the  paired  t-test,  when  com-
paring  initial  and  resolution  values  for  CPK  (p  <  0.002),
CK-MB  (p  <  0.0003),  LDH  (p  <  0.006)  and  AST  (p  <  0.008),  and
AST/ALT  ratio  (p  <  0.0001),  but  the  difference  was  not  sig-
niﬁcant  for  ALT.
The  normalization  of  blood  count  parameters  and  acute
phase  reactants,  shown  in  Table  2,  also  indicated  statistical
difference  between  the  initial  and  resolution  parameters
for  the  absolute  count  of  leukocytes  (p  <  0.0001),  neu-
trophils  (p  <  0.0004),  lymphocytes  (p  <  0.0001),  and  platelets
(p  <  0.005),  but  there  was  no  signiﬁcant  difference  between
baseline  and  resolution  parameters  for  hemoglobin,  C-
reactive  protein,  and  ESR.
The  time  interval  between  measurements  at  presenta-
tion  and  resolution  was  variable  (67  ±  78)  days.  Recurrence
occurred  in  one  case,  with  two  distinct  episodes,  the  ﬁrst
at  8.3  years  and  the  second  at  9.1  years.  Only  the  ﬁrst
episode  was  considered  in  the  analysis.  The  initial  diagnosis
was  acute  viral  myositis  in  both.  The  clinical  characteristics
s
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f  the  ﬁrst  and  second  episodes  were  myalgia,  calf  pain,
imited  ambulation,  gait  abnormality,  and  localized  mus-
le  weakness  in  the  lower  limbs.  Symptom  duration  was
 days  in  the  ﬁrst  and  5  days  in  the  second  episode.  The
aboratory  proﬁle  was  similar  when  the  ﬁrst  and  second
pisodes  were  compared,  with  both  preceded  by  respiratory
ymptoms.
In  this  series,  the  time  of  musculoskeletal  symptom
esolution  ranged  from  1  to  16  days.  There  were  other  man-
festations,  which  were  recorded  in  20%  of  cases,  including
iagnoses  of  sinusitis,  pneumonia,  and  transient  hip  syn-
vitis.  The  differential  and  exclusion  diagnoses  recorded  in
he  emergency  room  due  to  limited  ambulation  were:  non-
peciﬁc  synovitis,  hip  synovitis,  Guillain--Barre  syndrome,
rimary  neuromuscular  disease,  and  dermatomyositis.
iscussion
his  series  showed  a  higher  number  of  cases  of  acute  viral
yositis  between  2004  and  2006,  with  an  annual  distribution
n  the  cold  months,  with  no  other  apparent  explanation.
here  was  a  3:1  predominance  in  the  male  gender  and
ost  cases  were  treated  ﬁrst  in  the  emergency  depart-
ent,  which  indicates  its  impact  on  children’s  health.  The
ecognition  of  respiratory  manifestations  associated  with
usculoskeletal  symptoms  led  to  the  clinical  suspicion,
ubsequently  conﬁrmed  by  the  marked  elevation  in  mus-
le  enzymes,  especially  CPK,  in  addition  to  other  muscle
nzymes  such  as  LDH  and  AST;  however,  aldolase,  another
nzyme  with  muscle  inﬂammation  speciﬁcity,  was  not  avail-
ble.
In  addition  to  the  preceding  respiratory  symptoms  indi-
ating  a  common  hematological  response  to  viral  infections,
rone  to  transient  leukopenia,  as  well  as  nonspeciﬁc  and
ubtle  changes  of  acute  phase  reaction,  the  suspected
iagnosis  was  conﬁrmed  by  self-limited  musculoskeletal
ymptoms,  by  serial  measurement  of  muscle  enzymes  in
ases  of  calf  pain  and  refusal  to  walk  or  gait  impairment,
n  association  with  inﬂuenza  symptoms.
The  inﬂuenza  virus  and  other  respiratory  viruses  can
ause  acute  and  self-limited  febrile  illness,  occurring  in  out-
reaks,  frequently  in  the  winter.  A  variety  of  associated
omplications  are  known,  including  respiratory  ones,  such  as
rimary  viral  pneumonia  with  or  without  secondary  bacterial
nfections,  laryngitis,  bronchitis,  and  bronchiolitis.  Non-
espiratory  complications,  such  as  myositis,  myocarditis,
septic  meningitis,  and  encephalitis,  occur  less  frequently.12
The  frequency  of  acute  viral  myositis  is  proportionally
igher  in  type  B  inﬂuenza,  with  male  individuals  more  often
ffected  than  females.5 Myositis  may  also  be  caused  by  bac-
erial,  fungal,  and  parasitic  infections.13 Other  infectious
iseases  may  be  associated  with  myalgia,  with  or  with-
ut  myositis,  including,  in  addition  to  inﬂuenza,  dengue,
ickettsiosis,  infective  endocarditis,  toxoplasmosis,  Lyme
isease,  and  human  immunodeﬁciency  virus  (HIV)  infection.
he  bacterial  etiology  by  pyogenic  agents  is  called  pyomyosi-
is  and  may  have  an  acute  and  more  severe  evolution,  butchool-age  children,  clearly  related  to  mechanical  trauma
n  these  muscle  groups,  such  as  the  quadriceps  and  gluteus
uscles.
446  Cardin  SP  et  al.
Table  2  Laboratory  parameters  at  presentation  and  at  follow-up  of  acute  viral  myositis.
Laboratory  parametera Initial  value  (mean  ±  SD)  Final  value  (mean  ±  SD)  Paired  t-test
Creatine-phosphokinase  (CPK,  U/L)  (5507  ±  9180)  (127  ±  59)  p  <  0.002
MB fraction  (CKMB,  U/L) (96  ±  96) (28  ±  57)  p  <  0.0003
Lactate dehydrogenase  (LDH,  U/L)  (827  ±  598)  (520  ±  233)  p  <  0.0003
Transaminase  (AST,  U/L)  (199  ±  245)  (57  ±  129)  p  <  0.008
Transaminase  (ALT,  U/L)  (68  ±  66)  (44  ±  45)  NS
AST/ALT ratio  (3  ±  1.48)  (1  ±  0)  p  <  0.0001
Hemoglobin  (Hb,  mg/dL)  (13  ±  0.93)  (13  ±  1)  NS
Leukocytes  (absolute  n/mm3)  (4.59  ±  1.42)  ×  103 (8.07  ±  2.72)  ×  103 p  <  0.0001
Neutrophils  (absolute  n/mm3)  (2  ±  0.88)  ×  103 (4.02  ±  1.93)  ×  103 p  <  0.0004
Lymphocytes  (absolute  n/mm3) (2.02  ±  0.76)  ×  103 (2.93  ±  0.89)  ×  103 p  <  0.0001
Platelets (absolute  n/mm3) (206  ±  59)  ×  103 (332  ±  164)  ×  103 p  <  0.0005
ESR (mm/h)  (17  ±  10)  (13  ±  13)  NS
C-reactive protein  (CRP  mg/dL)  (0.4  ±  0.8)  (1  ±  4)  NS
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RNS, non-signiﬁcant.
a Reference values: CPK: 0--80 U/L, CKMB: 0--6 U/L, LDH: 313--61
Among  the  parasitic  infections,  cysticercosis,  schistoso-
iasis,  and  trichinosis  can  cause  symptoms  such  as  myalgia
nd  fever,  accompanied  by  eosinophilia.  The  diagnosis  of
uscular  involvement  in  these  cases  is  most  commonly  per-
ormed  by  identiﬁcation  of  calciﬁed  cysts  on  radiographs
nd  the  pseudo-hypertrophy  of  the  thigh  and  calf  muscles  in
he  disseminated  forms.  The  optimal  diagnosis  of  acute  viral
yositis  can  be  attained  by  viral  identiﬁcation,  by  serology,
r  by  biopsy,  in  the  presence  of  nonspeciﬁc  musculoskeletal
ymptoms.
Other  investigations,  such  as  electromyography,  have  a
imiting  factor,  i.e.,  the  invasiveness  of  the  technique  and
he  cost-beneﬁt  ratio,  in  practice.  In  spite  of  the  identi-
cation  failure  by  serology,6,7 studies  have  identiﬁed  the
nﬂuenza  virus  in  muscle  tissue  of  patients  affected  by  acute
iral  myositis.  However,  its  etiopathogenic  mechanisms  are
till  unknown.  There  is  a  hypothesis  of  muscle  damage  by
mmune  mechanism  or  muscle  tissue  invasion  by  viral  par-
icles,  causing  damage  to  muscle  ﬁbers.  There  is  evidence
f  viral  particles  isolated  from  calf  muscles  biopsies  with  no
peciﬁc  degenerative  alterations  and  myonecrosis.13 Among
he  complications,  rhabdomyolysis,  although  rare,  can  result
n  kidney  damage  secondary  to  myoglobinuria. 14
Acute  viral  myositis  associated  with  pandemic  inﬂuenza
1N1  has  been  reported  in  children  and  adults,15,16 with  one
f  the  cases  showing  orbital  muscle  involvement,  charac-
erizing  a  rare  form  of  orbital  myositis15 in  an  infant.  The
ecent  pandemic,  as  well  as  all  historical  cycles  of  epidemic
nd  seasonal  inﬂuenza,  have  indicated  the  beneﬁts  of  mass
accination.
The  present  study  was  conducted  during  a  period  when
accination  for  seasonal  inﬂuenza  had  limited  coverage  in
he  public  health  care  system  and  documentation  of  spe-
iﬁc  vaccination  in  this  series  was  not  discriminated.  The
ssociation  between  the  immune  status  for  inﬂuenza  vac-
ination  and  the  risk  of  acute  viral  myositis  is  unknown.
lthough  patients  that  received  the  seasonal  inﬂuenza  vac-
ine  could  admittedly  have  a  lower  risk  of  respiratory
omplications  (e.g.,  pneumonia,  otitis  media),  there  is
o  clear  demonstration  of  decrease  in  other  secondary
omplications., AST: 17--37 U/L, ALT: 30--65 U/L, ESR < 20 mm/h, CRP < 1 mg/dL.
Among  the  limitations  of  this  study,  the  following  should
e  considered:  the  small  size  of  the  series,  treatment  at  a
peciﬁc  hospital,  and  the  retrospective  study  design.  Ide-
lly,  prospective  population  studies  would  provide  the  best
escription  of  acute  viral  myositis  incidence.5 The  associ-
tion  with  the  identiﬁcation  of  respiratory  viruses  was  not
ossible.17,18 Despite  these  limitations,  the  results  indicate
ome  recommendations,  such  as  the  systematic  evaluation
f  children  with  lower-limb  myalgia  in  the  presence  of  respi-
atory  symptoms  and  follow-up  with  serial  measurement
f  muscle  enzymes,  especially  CPK,  consistent  with  recent
bservations.19
Most  children  with  acute  viral  myositis  are  treated
n  the  emergency  department,20,21 as  the  symptoms  can
e  alarming  for  parents,  with  a  tendency  toward  mul-
iple  consultations  with  various  specialties  and  costly
nvestigations.4,11,22 The  pediatrician  in  the  emergency  care
ervice  should  feel  comfortable  to  discharge  the  patient,
aking  the  differential  diagnosis  with  neuromuscular  dis-
ases,  checking  during  the  follow-up  to  review  symptoms
nd  the  measurement  of  muscle  enzymes  until  normaliza-
ion.
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